Nature Genet. 23, 222–227 (1999).
In the abstract, "ES cells" were indicated to be embryonic stem cells, when in fact they were Ewing sarcoma cells.
Additional information
The online version of the original article can be found at 10.1038/13854
Rights and permissions
About this article
Cite this article
Hahm, KB. Correction: Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet 23, 481 (1999). https://doi.org/10.1038/70611
Issue Date:
DOI: https://doi.org/10.1038/70611
This article is cited by
-
A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing’s sarcoma cells, interacts with the EWS-FLI1 and partner proteins
Scientific Reports (2017)
-
Junction region of EWS-FLI1 fusion protein has a dominant negative effect in Ewing’s Sarcoma in vitro
BMC Cancer (2012)
-
Off-target effects dominate a large-scale RNAi screen for modulators of the TGF-β pathway and reveal microRNA regulation of TGFBR2
Silence (2011)
-
Transcription factor Dlx2 protects from TGFβ-induced cell-cycle arrest and apoptosis
The EMBO Journal (2011)
-
Localizing potentially active post-transcriptional regulations in the Ewing's sarcoma gene regulatory network
BMC Systems Biology (2010)
